PhaseRx (PZRX) Shares Double

November 28, 2016 10:12 AM EST
Get Alerts PZRX Hot Sheet
Trade PZRX Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

PhaseRx (NASDAQ: PZRX) surged Monday after announcing orphan drug designation for the treatment of Ornithine Transcarbamylase Deficiency. Shares advance over 100%.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Momentum Movers, Trader Talk

Add Your Comment